Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, announces it has completed its acquisition of Noctrix Health, Inc., a medical device company developing clinically validated wearable therapeutics for chronic neurological disorders. The acquisition expands Resmed’s clinical sleep health portfolio into an adjacent area of significant unmet need — the treatment of Restless Legs Syndrome (RLS), the third most prevalent sleep disorder. For Noctrix Health, joining Resmed brings an opportunity to scale its innovation, expand patient access, and accelerate impact for providers, patients and health systems.
Read the full article: Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio //
Source: https://www.globenewswire.com/news-release/2026/06/01/3304704/0/en/resmed-completes-acquisition-of-noctrix-health-expanding-clinical-sleep-health-portfolio.html?_gl=1*18r94cq*_up*MQ..*_ga*MTMzMjk0Njk4OC4xNzgwMzgxNTE3*_ga_ERWPGTJ5X8*czE3ODAzODE1MTckbzEkZzAkdDE3ODAzODE1MTckajYwJGwwJGgw*_ga_B6167QB2TF*czE3ODAzODE1MTckbzEkZzAkdDE3ODAzODE1MTckajYwJGwwJGg0MjE2ODIwMDc.